Drugs / Hugeltox
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01791881 | Apr 2008 → May 2009 | benign essential blepharospasm | Hugel | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hugel-Tox | “To compare the efficacy and safety of Hugel-Tox (Botulinum toxin A, Hugel, Korea) against Botox in the treatment of Essential Blepharospasm” NCT01791881 ↗1“Botulinum toxin type A(Hugeltox)” NCT01791881 ↗ |
| Modality | Protein / enzyme biologic | “Botulinum toxin A” NCT01791881 ↗ |